Researchers have given the gene therapy made at UManchester to two out of five planned patients in a Phase I/II trial, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback